Irinotecan pharmacokinetics-pharmacodynamics: the clinical relevance of prolonged exposure to SN-38

We have shown previously that the terminal disposition half-life of SN-38, the active metabolite of irinotecan, is much longer than earlier thought. Currently, it is not known whether this prolonged exposure has any relevance toward SN-38-induced toxicity. Here, we found that SN-38 concentrations pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathijssen, R H J, Verweij, J, Loos, W J, de Bruijn, P, Nooter, K, Sparreboom, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376117/
https://www.ncbi.nlm.nih.gov/pubmed/12107833
http://dx.doi.org/10.1038/sj.bjc.6600447

Ejemplares similares

Ejemplares similares